Vice President, Quality

Remix Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class of medicines that modulate RNA splicing to address the underlying biology of disease. Our lead program, REM-422, targets pre-mRNA splicing in oncology and represents a fundamentally differentiated approach to drug discovery. Headquartered in Watertown, MA, Remix is advancing its pipeline with the urgency and scientific rigor that patients deserve. 

Remix is seeking an exceptional Vice President of Quality to serve as the architect and guardian of our quality organization at a pivotal moment in our growth. Reporting to the Chief Operating Officer, this leader will define the global quality vision and build the systems, culture, and capabilities required to advance REM-422 from clinical development through potential commercialization. 

This is a rare opportunity to build a world-class quality function from the ground up within a science-driven organization where quality is understood as a patient safety imperative — not a compliance afterthought. The VP of Quality will bring deep expertise across GxP disciplines, a risk-based mindset, and the leadership presence to inspire confidence across internal teams, external partners, and Health Authorities alike. 

• Masters degree or higher in Biology, Chemistry, Pharmaceutical Sciences, Engineering, or a related scientific discipline 

• 15+ years of progressive pharmaceutical/biotech industry experience, with 10+ years in quality management and leadership roles of increasing scope 

• Proven track record building, leading, and scaling quality organizations at clinical-stage and/or commercial-stage companies 

• Deep expertise in GCP and GMP compliance 

• Demonstrated success leading or hosting FDA and/or EMA GxP inspections; direct experience managing inspection responses and regulatory action items 

• Expert knowledge of FDA, EMA, and ICH guidelines and regulations applicable across the drug development lifecycle 

• Experience providing quality oversight of small molecule CMOs and clinical CROs in a virtual or hybrid operating model 

• Exceptional leadership presence, integrity, and judgment; thrives in a dynamic, fast-paced environment where agility and accountability coexist 

• Familiarity with oncology drug development and oncology-specific clinical quality considerations 

• Working knowledge of EU GMP requirements and experience with dual US/EU regulatory programs 

$293,000 - $358,000 USD

This range reflects the expected base salary for this position, plus bonus, equity, and benefits as applicable.  Actual salaries may vary based on factors, such as skill, experience, and qualification for the role.